pSMT3-FBF2 AS/Y
(Plasmid
#166974)
-
PurposeExpresses FBF-2 with AS/Y mutations in repeat 5 in E. coli for purification and crystallization studies
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 166974 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSMT3
-
Backbone manufacturerChris Lima
- Backbone size w/o insert (bp) 5633
- Total vector size (bp) 6869
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFBF-2
-
Alt nameFBF
-
SpeciesC. elegans (nematode)
-
MutationFBF-2 PUM RNA binding domain; amino acids 164-575; changed cysteine 363 to alanine, changed arginine 364 to tyrosine, changed glutamine 367 to serine
-
Entrez Genefbf-2 (a.k.a. CELE_F21H12.5)
- Promoter T7
-
Tag
/ Fusion Protein
- His-SUMO (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamH1 (unknown if destroyed)
- 3′ cloning site Not1 (unknown if destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7 term (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSMT3-FBF2 AS/Y was a gift from Traci Hall (Addgene plasmid # 166974 ; http://n2t.net/addgene:166974 ; RRID:Addgene_166974) -
For your References section:
Engineering a conserved RNA regulatory protein repurposes its biological function in vivo. Bhat VD, McCann KL, Wang Y, Fonseca DR, Shukla T, Alexander JC, Qiu C, Wickens M, Lo TW, Tanaka Hall TM, Campbell ZT. Elife. 2019 Jan 17;8. pii: 43788. doi: 10.7554/eLife.43788. 10.7554/eLife.43788 PubMed 30652968